Fifth Chakra (throat)
Generic Name: fifth chakra (throat)
Brand Names:
Fifth Chakra (throat) 7305
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS Temporarily relieves arrogance, shyness, fear of speaking, inability to express thoughts or feelings, social anxiousness, stubbornness, or fear of being detached from others.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 5 drops up to 4 times per day for up to one month. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Fifth Chakra (throat) used for?▼
INDICATIONS Temporarily relieves arrogance, shyness, fear of speaking, inability to express thoughts or feelings, social anxiousness, stubbornness, or fear of being detached from others.*
Can I take Fifth Chakra (throat) during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Fifth Chakra (throat)?▼
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Troglitazone
troglitazone
Manufactured by SANKYO. Dosage form: TABLET. Route: ORAL. Active ingredients: TROGLITAZONE (400MG). Application: NDA020719.
Pioglitazone And Glimepiride
pioglitazone and glimepiride
Sulfonylurea [EPC]
11 DESCRIPTION Pioglitazone and glimepiride tablets are a thiazolidinedione and a sulfonylurea combination product that contains two oral antihyperglycemic agents: pioglitazone and glimepiride. The concomitant use of pioglitazone and a sulfonylurea, the class of drugs that includes glimepiride, has been previously approved based on clinical trials in patients with type 2 diabetes inadequately controlled on a sulfonylurea.
Oak Mix
oak mix
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: QUERCUS ALBA POLLEN (20000 [PNU]/mL); QUERCUS RUBRA POLLEN (20000 [PNU]/mL); QUERCUS VIRGINIANA POLLEN (20000 [PNU]/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.